Search

Evelyn Y. Pyla

Examiner (ID: 11592, Phone: (571)270-7366 , Office: P/1651 )

Most Active Art Unit
1633
Art Unit(s)
1651, 1633, 4141
Total Applications
649
Issued Applications
307
Pending Applications
80
Abandoned Applications
273

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17688136 [patent_doc_number] => 20220195428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => OLIGONUCLEOTIDES AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION [patent_app_type] => utility [patent_app_number] => 17/310235 [patent_app_country] => US [patent_app_date] => 2020-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310235 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310235
OLIGONUCLEOTIDES AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION Jan 28, 2020 Pending
Array ( [id] => 17548499 [patent_doc_number] => 20220119840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => CLOSED-ENDED DNA (CEDNA) AND USE IN METHODS OF REDUCING GENE OR NUCLEIC ACID THERAPY RELATED IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 17/424199 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424199 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/424199
CLOSED-ENDED DNA (CEDNA) AND USE IN METHODS OF REDUCING GENE OR NUCLEIC ACID THERAPY RELATED IMMUNE RESPONSE Jan 23, 2020 Abandoned
Array ( [id] => 16009457 [patent_doc_number] => 20200179571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => CELL REPOPULATED COLLAGEN MATRIX FOR SOFT TISSUE REPAIR AND REGENERATION [patent_app_type] => utility [patent_app_number] => 16/744095 [patent_app_country] => US [patent_app_date] => 2020-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10783 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744095 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/744095
Cell repopulated collagen matrix for soft tissue repair and regeneration Jan 14, 2020 Issued
Array ( [id] => 16901094 [patent_doc_number] => 20210180010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => METHODS OF USING CURVATURE-DEFINED SURFACES WITH VARYING CURVATURES TO DIRECT CELL ATTACHMENT, SPREADING, AND MIGRATION [patent_app_type] => utility [patent_app_number] => 16/713889 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713889 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/713889
METHODS OF USING CURVATURE-DEFINED SURFACES WITH VARYING CURVATURES TO DIRECT CELL ATTACHMENT, SPREADING, AND MIGRATION Dec 12, 2019 Abandoned
Array ( [id] => 16901096 [patent_doc_number] => 20210180012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => CURVATURE-DEFINED CONCAVE AND CONVEX PDMS SURFACES FOR USE IN CELL AND TISSUE CULTURING AND IN OTHER SURFACE AND INTERFACE APPLICATIONS [patent_app_type] => utility [patent_app_number] => 16/713644 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 881 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713644 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/713644
Curvature-defined concave and convex PDMS surfaces for use in cell and tissue culturing and in other surface and interface applications Dec 12, 2019 Issued
Array ( [id] => 16901093 [patent_doc_number] => 20210180009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => CURVATURE-DEFINED CONVEX AND CONCAVE GEL SURFACES FOR USE IN CELL AND TISSUE CULTURING AND IN OTHER SURFACE AND INTERFACE APPLICATIONS [patent_app_type] => utility [patent_app_number] => 16/713756 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22882 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 491 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713756 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/713756
Curvature-defined convex and concave gel surfaces for use in cell and tissue culturing and in other surface and interface applications Dec 12, 2019 Issued
Array ( [id] => 16189328 [patent_doc_number] => 20200230177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => IMPLANTS, METHODS FOR MAKING IMPLANTS AND METHODS OF TREATING LIPOATROPHY DEFECTS THEREWITH [patent_app_type] => utility [patent_app_number] => 16/708725 [patent_app_country] => US [patent_app_date] => 2019-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708725 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/708725
IMPLANTS, METHODS FOR MAKING IMPLANTS AND METHODS OF TREATING LIPOATROPHY DEFECTS THEREWITH Dec 9, 2019 Abandoned
Array ( [id] => 16177199 [patent_doc_number] => 20200224167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => Direct effect of extracted BMP on Mesenchymal Stem Cell Differentiation for use in a Culture Medium, Diagnostic Assay, and Adjunct or Stand-Alone Pharmaceutical Treatment [patent_app_type] => utility [patent_app_number] => 16/708169 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7560 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708169 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/708169
Direct effect of extracted BMP on Mesenchymal Stem Cell Differentiation for use in a Culture Medium, Diagnostic Assay, and Adjunct or Stand-Alone Pharmaceutical Treatment Dec 8, 2019 Abandoned
Array ( [id] => 16854750 [patent_doc_number] => 20210155495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => COMPOSITION FOR ANTIFREEZING [patent_app_type] => utility [patent_app_number] => 16/702245 [patent_app_country] => US [patent_app_date] => 2019-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4084 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702245 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/702245
Composition for antifreezing Dec 2, 2019 Issued
Array ( [id] => 17291031 [patent_doc_number] => 20210386870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => Fibroblast growth factor 21 (FGF21) gene therapy [patent_app_type] => utility [patent_app_number] => 17/295453 [patent_app_country] => US [patent_app_date] => 2019-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295453
Fibroblast growth factor 21 (FGF21) gene therapy Nov 25, 2019 Pending
Array ( [id] => 15711539 [patent_doc_number] => 20200102535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => METHOD FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELLS [patent_app_type] => utility [patent_app_number] => 16/692484 [patent_app_country] => US [patent_app_date] => 2019-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16692484 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/692484
Method for producing retinal tissue and retina-related cells Nov 21, 2019 Issued
Array ( [id] => 18369120 [patent_doc_number] => 11649274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Method for producing mesenchymal stem cell and application of same [patent_app_type] => utility [patent_app_number] => 16/678873 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7687 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678873 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/678873
Method for producing mesenchymal stem cell and application of same Nov 7, 2019 Issued
Array ( [id] => 17299851 [patent_doc_number] => 20210395690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => ANCHORAGE-INDEPENDENT CELLS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/292303 [patent_app_country] => US [patent_app_date] => 2019-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292303 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292303
ANCHORAGE-INDEPENDENT CELLS AND USE THEREOF Nov 6, 2019 Pending
Array ( [id] => 17392530 [patent_doc_number] => 11241518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Cartilage regenerative material [patent_app_type] => utility [patent_app_number] => 16/660003 [patent_app_country] => US [patent_app_date] => 2019-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15139 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660003 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/660003
Cartilage regenerative material Oct 21, 2019 Issued
Array ( [id] => 16429667 [patent_doc_number] => 10829739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Progenitor cells of mesodermal lineage [patent_app_type] => utility [patent_app_number] => 16/596301 [patent_app_country] => US [patent_app_date] => 2019-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 11883 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16596301 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/596301
Progenitor cells of mesodermal lineage Oct 7, 2019 Issued
Array ( [id] => 15738575 [patent_doc_number] => 20200108175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => XENOTRANSPLANTATION PRODUCTS AND METHODS [patent_app_type] => utility [patent_app_number] => 16/593785 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67443 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 282 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593785 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/593785
Xenotransplantation products and methods Oct 3, 2019 Issued
Array ( [id] => 15436065 [patent_doc_number] => 20200032216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => CELL CULTIVATION METHOD, CELL SUPPORT COMPOSITE PRODUCTION METHOD, CULTIVATED CELLS, AND CELL SUPPORT COMPOSITE [patent_app_type] => utility [patent_app_number] => 16/593462 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16419 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593462 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/593462
Cell cultivation method, cell support composite production method, cultivated cells, and cell support composite Oct 3, 2019 Issued
Array ( [id] => 18179874 [patent_doc_number] => 20230040603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS [patent_app_type] => utility [patent_app_number] => 17/281378 [patent_app_country] => US [patent_app_date] => 2019-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42427 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/281378
Compositions useful for treating GM1 gangliosidosis Sep 29, 2019 Issued
Array ( [id] => 18151441 [patent_doc_number] => 11564388 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-31 [patent_title] => Supercooling methods for preservation of biological samples [patent_app_type] => utility [patent_app_number] => 16/583895 [patent_app_country] => US [patent_app_date] => 2019-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 35 [patent_no_of_words] => 32004 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16583895 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/583895
Supercooling methods for preservation of biological samples Sep 25, 2019 Issued
Array ( [id] => 15435999 [patent_doc_number] => 20200032183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => METHOD OF MANUFACTURING CELL STRUCTURE [patent_app_type] => utility [patent_app_number] => 16/573126 [patent_app_country] => US [patent_app_date] => 2019-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17236 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16573126 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/573126
METHOD OF MANUFACTURING CELL STRUCTURE Sep 16, 2019 Abandoned
Menu